Alizée received an MS in bioengineering and biotechnology from EPFL (École Polytechnique Fédérale de Lausanne) in Switzerland. She completed her PhD in immunoengineering, in part at the University of Chicago, in 2016.
Alizée's research includes mechanisms of tolerance induction by erythrocyte-targeted antigens.